Risk factors and transitional probability of clinical events in Korean CKD patients using the multistate model

被引:0
|
作者
Kim, Ji Hye [1 ]
Kim, Jinheum [2 ]
Kim, Jayoun [3 ]
Jung, Ji Yong [4 ]
Jeong, Jong Cheol [5 ]
Han, Seung Hyeok [6 ]
Oh, Kook-Hwan [7 ]
机构
[1] Chungbuk Natl Univ Hosp, Dept Internal Med, Cheongju, South Korea
[2] Univ Suwon, Dept Appl Stat, Hwaseong, South Korea
[3] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea
[4] Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea
[5] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea
[6] Yonsei Univ, Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea
[7] Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea
来源
SCIENTIFIC REPORTS | 2025年 / 15卷 / 01期
关键词
Chronic kidney disease; End stage kidney disease; Cardiovascular disease; Multistate model; CHRONIC KIDNEY-DISEASE; RENAL-INSUFFICIENCY COHORT; CARDIOVASCULAR-DISEASE; MORTALITY; HEART; EPIDEMIOLOGY; ASSOCIATION;
D O I
10.1038/s41598-024-82426-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Korean chronic kidney disease (CKD) patients have relatively low cardiovascular disease (CVD) and high end stage kidney disease (ESKD) incidence rates. Using the multi-state model this study analyzed the 5- and 10-year cumulative hazard estimates, transition probabilities and risk factors associated with the five clinical transitions; ESKD, CVD, CVD to death, ESKD to death and death. CKD stages 1-4 patients from the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease cohort were included. Multivariable multi-state model analysis was performed to investigate the study outcomes associated with the five transitions. Among the 1502 patients (median age 54 years, male 61.3%), the overall prevalence of clinical events were: ESKD (22.6%), CVD (7.5%), death after ESKD (3.6%), death (3.3%) and death after CVD (1.2%). Patients who experienced intermediate ESKD event had higher risk of death than those who experienced CVD event (10-year cumulative hazard: 0.35; 95% CI: 0.23, 0.48 vs. 0.27; 95% CI: 0.15, 0.40). The 10-year transition probability was highest for enrollment to ESKD (0.27; 95% CI: (0.23, 0.31)) followed by enrollment to CVD (0.08; 95% CI: 0.07, 0.10). Different clinical risk factors were associated with each of the five transitions. Patients who experienced intermediate ESKD event were more exposed to death risk than those who experienced CVD and the highest 10-year progression probability was for enrollment to ESKD followed by death after ESKD. Different risk factors were associated with varying transitions. These findings correlate with the distinctive clinical features of Korean CKD patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes-A Systematic Literature Review
    Palaka, Eirini
    Grandy, Susan
    van Haalen, Heleen
    McEwan, Phil
    Darlington, Oliver
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2020, 2020
  • [22] Comparison of Mineral Metabolites as Risk Factors for Adverse Clinical Outcomes in CKD
    Isakova, Tamara
    SEMINARS IN NEPHROLOGY, 2013, 33 (02) : 106 - 117
  • [23] Silent Cerebral Microbleeds and Longitudinal Risk of Renal and Cardiovascular Events in Patients with CKD
    Shima, Hideaki
    Mori, Tatsuhiko
    Ooi, Masayuki
    Sonoda, Mika
    Shoji, Tetsuo
    Lshimura, Eiji
    Okamura, Mikio
    Ishizaka, Nobukazu
    Inaba, Masaaki
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (09): : 1557 - 1565
  • [24] Low High-Sensitivity C-Reactive Protein Level in Korean Patients With Chronic Kidney Disease and Its Predictive Significance for Cardiovascular Events, Mortality, and Adverse Kidney Outcomes: Results From KNOW-CKD
    Lee, Changhyun
    Park, Keun Hyung
    Joo, Young Su
    Nam, Ki Heon
    Chang, Tae-Ik
    Kang, Ea Wha
    Lee, Joongyub
    Oh, Yun Kyu
    Jung, Ji Yong
    Ahn, Curie
    Lee, Kyu-Beck
    Park, Jung Tak
    Yoo, Tae-Hyun
    Kang, Shin-Wook
    Han, Seung Hyeok
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (21):
  • [25] Nomogram Model Based on Clinical Risk Factors and Heart Rate Variability for Predicting All-Cause Mortality in Stage 5 CKD Patients
    Gao, Xueyan
    Wang, Jing
    Huang, Hui
    Ye, Xiaoxue
    Cui, Ying
    Ren, Wenkai
    Xu, Fangyan
    Qian, Hanyang
    Gao, Zhanhui
    Zeng, Ming
    Yang, Guang
    Huang, Yaoyu
    Tang, Shaowen
    Xing, Changying
    Wan, Huiting
    Zhang, Lina
    Chen, Huimin
    Jiang, Yao
    Zhang, Jing
    Xiao, Yujie
    Bian, Anning
    Li, Fan
    Wei, Yongyue
    Wang, Ningning
    FRONTIERS IN GENETICS, 2022, 13
  • [26] Prolactin Levels, Endothelial Dysfunction, and the Risk of Cardiovascular Events and Mortality in Patients with CKD
    Carrero, Juan Jesus
    Kyriazis, John
    Sonmez, Alper
    Tzanakis, Ioannis
    Qureshi, Abdul Rashid
    Stenvinkel, Peter
    Saglam, Mutlu
    Stylianou, Kostas
    Yaman, Halil
    Taslipinar, Abdullah
    Vural, Abdulgaffar
    Gok, Mahmut
    Yenicesu, Mujdat
    Daphnis, Eugene
    Yilmaz, Mahmut Ilker
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (02): : 207 - 215
  • [27] Managing cardiovascular risk factors in patients with chronic kidney disease: pharmacological and non-pharmacological interventions in the Copenhagen CKD Cohort
    Ballegaard, Ellen Linnea Freese
    Carlson, Nicholas
    Jorgensen, Morten Buus
    Sorensen, Ida Maria Hjelm
    Trankjaer, Helene
    Almarsdottir, Anna Birna
    Bro, Susanne
    Feldt-Rasmussen, Bo
    Kamper, Anne-Lise
    CLINICAL KIDNEY JOURNAL, 2024, 17 (07)
  • [28] Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
    Inaguma, Daijo
    Imai, Enyu
    Takeuchi, Ayano
    Ohashi, Yasuo
    Watanabe, Tsuyoshi
    Nitta, Kosaku
    Akizawa, Tadao
    Matsuo, Seiichi
    Makino, Hirofumi
    Hishida, Akira
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (03) : 446 - 456
  • [29] Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan
    Hamano, Takayuki
    Yamaguchi, Yusuke
    Goto, Kashia
    Mizokawa, Sho
    Ito, Yuichiro
    Dellanna, Frank
    Barratt, Jonathan
    Akizawa, Tadao
    ADVANCES IN THERAPY, 2024, 41 (04) : 1512 - 1525
  • [30] Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan
    Takayuki Hamano
    Yusuke Yamaguchi
    Kashia Goto
    Sho Mizokawa
    Yuichiro Ito
    Frank Dellanna
    Jonathan Barratt
    Tadao Akizawa
    Advances in Therapy, 2024, 41 : 1526 - 1552